Park Ha Biological Technology Co., Ltd. Ordinary Shares
Here’s whether Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+6.17% over 10 days); RSI 55 — healthy momentum range; 3-month momentum positive (+26.7%); rising volume confirms the move (2.99x 30d avg). Currently 92.8% off its 52-week high. Score: +5/7.
BYAH is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 54.6 sits in the neutral zone — momentum is neither stretched nor exhausted. With ~7 months of trading history, the return since first available bar is -92.1%. The current 92.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.